R&D gap stymies access to children’s medicines
Why we need a more precise understanding of vaccine hesitation
1 April 2021Poor judgment of autistic adults
1 April 2021R&D gap stymies access to children’s medicines
Only about six percent of research and development (R&D) projects from 20 leading global pharmaceutical companies target children, despite major gaps in the pediatric medicines pipeline, a report shows.
